These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27091854)

  • 21. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).
    Lüke M; Ziemssen F; Völker M; Altpeter E; Beutel J; Besch D; Bartz-Schmidt KU; Gelisken F
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):745-54. PubMed ID: 19214552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macular pigment spatial distribution effects on glare disability.
    Putnam CM; Bassi CJ
    J Optom; 2015; 8(4):258-65. PubMed ID: 25697374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.
    Thompson AC; Luhmann UFO; Stinnett SS; Vajzovic L; Horne A; Toth CA; Cousins SW; Lad EM
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):289-297. PubMed ID: 29340643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
    Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration.
    Pondorfer SG; Wintergerst MWM; Gorgi Zadeh S; Schultz T; Heinemann M; Holz FG; Finger RP
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):55. PubMed ID: 32232348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases.
    Crosby-Nwaobi R; Hykin P; Peto T; Sivaprasad S
    Clin Ophthalmol; 2016; 10():835-44. PubMed ID: 27274188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
    Maguire M;
    Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macular Inner Retinal Layer Thickness in Relation to Photopic and Mesopic Contrast Sensitivity in Healthy Young and Older Subjects.
    Puell MC; Palomo-Álvarez C; Pérez-Carrasco MJ
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5487-5493. PubMed ID: 30452603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual function tests as potential biomarkers in age-related macular degeneration.
    Dimitrov PN; Robman LD; Varsamidis M; Aung KZ; Makeyeva GA; Guymer RH; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9457-69. PubMed ID: 22003115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.
    Müller S; Heeren TFC; Bonelli R; Fruttiger M; Charbel Issa P; Egan CA; Holz FG
    Br J Ophthalmol; 2019 Mar; 103(3):398-403. PubMed ID: 29858186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocular and Binocular Visual Function Assessments and Activities of Daily Living Performance in Age-Related Macular Degeneration.
    Peterson CL; Yap CL; Tan TF; Tan LLY; Sim KT; Ong L; Tan ZK; Tan YW; Man R; Fenwick E; Cheung G; Lamoureux E; Tan ACS
    Ophthalmol Retina; 2024 Jan; 8(1):32-41. PubMed ID: 37648064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
    Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
    Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macular pigment and visual performance under glare conditions.
    Stringham JM; Hammond BR
    Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast Sensitivity and Lateral Inhibition Are Enhanced With Macular Carotenoid Supplementation.
    Stringham JM; O'Brien KJ; Stringham NT
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2291-2295. PubMed ID: 28431432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Working-age cataract patients: visual results, reading performance, and quality of life with three diffractive multifocal intraocular lenses.
    Cillino G; Casuccio A; Pasti M; Bono V; Mencucci R; Cillino S
    Ophthalmology; 2014 Jan; 121(1):34-44. PubMed ID: 23953097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do we know about the macular pigment in AMD: the past, the present, and the future.
    Arunkumar R; Calvo CM; Conrady CD; Bernstein PS
    Eye (Lond); 2018 May; 32(5):992-1004. PubMed ID: 29576617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration.
    Stringham JM; Hammond BR; Nolan JM; Wooten BR; Mammen A; Smollon W; Snodderly DM
    Exp Eye Res; 2008 Nov; 87(5):445-53. PubMed ID: 18778703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort.
    Stringham JM; Garcia PV; Smith PA; McLin LN; Foutch BK
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7406-15. PubMed ID: 21296819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.